Physician profile
Mariah A Beasley
NPI 1043476831
$17,260.71
in general payments reported to CMS, 2019-2025
29 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,514 · 2020: $6,400 · 2021: $5,044 · 2022: $1,454 · 2023: $290 · 2024: $360 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,085.56 | 2019-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $551.76 | 2019 | |
| Novo Nordisk INC | $378.54 | 2019-2025 | Wegovy |
| Olympus America INC. | $220.79 | 2019-2024 | 4k Cable 8.5m |
| Ethicon US, LLC | $150.46 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2022 | |
| Conmed Corporation | $96.35 | 2023 | Airseal |
| Tela Bio, INC. | $78.43 | 2019 | |
| Allergan, INC. | $72.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.43 | 2024-2025 | Lifevest |
| Phathom Pharmaceuticals, INC. | $49.73 | 2024-2025 | Voquezna |
| Shire North American Group INC | $48.01 | 2019 | |
| Intra-Sana Laboratories | $45.55 | 2022-2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Lilly USA, LLC | $26.62 | 2019-2024 | Zepbound |
| Cook Medical LLC | $26.20 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.28 | 2025 | Parietene Ds |
| Baxter Healthcare | $22.93 | 2025 | Perclot |
| Daiichi Sankyo INC. | $20.86 | 2021 | |
| Genentech USA, INC. | $19.84 | 2025 | Ocrevus Zunovo |
| Solventum Corporation | $17.28 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Endo Pharmaceuticals INC. | $17.22 | 2019 | |
| Ucb, INC. | $17.13 | 2021 | |
| Teleflex LLC | $16.18 | 2023 | Titan Sgs Standard Gastric Stapler |
| Mallinckrodt Enterprises LLC | $16.01 | 2019 | |
| Covidien LP | $14.78 | 2019 | |
| Aroa Biosurgery Incorporated | $13.71 | 2019 | |
| Resmed Corp | $12.93 | 2023 | |
| Redhill Biopharma INC. | $12.75 | 2022 | |
| Kci USA, INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.